Laird Norton Wetherby Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,238
| Closed | -$375K | – | 968 |
|
|
2023
Q3 | $375K | Sell |
3,238
-249
| -7% | -$28.8K | 0.02% | 611 |
|
|
2023
Q2 | $359K | Sell |
3,487
-32
| -0.9% | -$3.29K | 0.02% | 652 |
|
|
2023
Q1 | $384K | Sell |
3,519
-58
| -2% | -$6.33K | 0.02% | 623 |
|
|
2022
Q4 | $407K | Buy |
3,577
+45
| +1% | +$5.12K | 0.03% | 583 |
|
|
2022
Q3 | $219K | Buy |
+3,532
| New | +$219K | 0.02% | 778 |
|
|
2022
Q2 | – | Sell |
-2,328
| Closed | -$245K | – | 980 |
|
|
2022
Q1 | $245K | Sell |
2,328
-127
| -5% | -$13.4K | 0.01% | 781 |
|
|
2021
Q4 | $265K | Buy |
2,455
+45
| +2% | +$4.86K | 0.01% | 758 |
|
|
2021
Q3 | $264K | Buy |
2,410
+161
| +7% | +$17.6K | 0.02% | 749 |
|
|
2021
Q2 | $211K | Buy |
+2,249
| New | +$211K | 0.01% | 839 |
|